ERBB2 and breast cancer: In particular, rs1136201 (A>G) in ERBB2, also referred to as the HER2 Ile655Val polymorphism, has been investigated as a susceptibility factor for breast cancer because Val-expressing cells exhibit increased proliferation and reduced apoptosis in vitro [30].